Fig. 3
From: Clinical significance of FBXO17 gene expression in high-grade glioma
FBXO17 predicts survival regardless of TMZ chemotherapy. a Kaplan-Meier OS curves for patients who received TMZ chemotherapy and patients who did not receive TMZ. b Association of FBXO17 expression with TMZ chemotherapy. c Kaplan-Meier OS curves for patients in the TMZ group after classifying patients into two groups based on FBXO17 gene expression. d Kaplan-Meier OS curves for patients in the non-TMZ group after classifying patients into two groups based on FBXO17 gene expression